Connect Biopharma HldgsCNTB
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 13 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holders were BML Capital Management, LLC ($1.2M), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ($148K) and Choreo, LLC ($88K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $6K |
| Exits | 2 | $81K |
All 13F filers, Q4 2024 → Q1 2025: 14,306 shares bought and 367,591 shares sold, net −353,285 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| BML Capital Management, LLC | 0.93% | No change | 2,093,232 | $1.2M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.00% | Reduce -47.3% | 268,946 | $148K |
| Choreo, LLC | 0.00% | No change | 160,867 | $88K |
| Renaissance Technologies | 0.00% | Reduce -14.8% | 114,800 | $63K |
| Callan Capital, LLC | 0.00% | No change | 80,000 | $44K |
| Royal Bank of Canada | 0.00% | Reduce -49.8% | 40,400 | $22K |
| Geode Capital Management, LLC | 0.00% | No change | 27,961 | $15K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 20,000 | $11K |
| ADAR1 Capital Management, LLC | 0.00% | New | 10,300 | $6K |
| UBS Group AG | 0.00% | Add +84.6% | 8,739 | $5K |
| Rhumbline Advisers | 0.00% | Reduce -75.0% | 2,370 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $67 |
| SBI Securities Co., Ltd. | 0.00% | No change | 6 | $3 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.